Class information for:
Level 1: KRN5500//SPICAMYCIN//SPICAMYCIN DERIVATIVE

Basic class information

Class id #P Avg. number of
references
Database coverage
of references
37262 62 22.8 60%



Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes

The table includes all classes above and classes immediately below the current class.



Cluster id Level Cluster label #P
3 4 PLANT SCIENCES//AGRONOMY//FOOD SCIENCE & TECHNOLOGY 1882812
2 3       INTEGRATIVE & COMPLEMENTARY MEDICINE//CHEMISTRY, MEDICINAL//ESSENTIAL OIL 193989
4029 2             DEGUELIN//CYPERUS ROTUNDUS//KRN5500 652
37262 1                   KRN5500//SPICAMYCIN//SPICAMYCIN DERIVATIVE 62

Terms with highest relevance score



rank Term termType Chi square Shr. of publ. in
class containing
term
Class's shr. of
term's tot. occurrences
#P with
term in
class
1 KRN5500 authKW 5065827 19% 86% 12
2 SPICAMYCIN authKW 3016630 11% 88% 7
3 SPICAMYCIN DERIVATIVE authKW 1477534 5% 100% 3
4 FUNCT PAIN NEUROIMAGING THER Y address 1313361 6% 67% 4
5 CENT 21142 NURUMIZU address 886518 5% 60% 3
6 3 D MODEL ANALYSIS authKW 492511 2% 100% 1
7 4 AMINO 4 DEOXYHEPTOSE authKW 492511 2% 100% 1
8 ANTIPLATELET AGGREGATORY authKW 492511 2% 100% 1
9 CANDIDATE ANTITUMOR DRUGS authKW 492511 2% 100% 1
10 DAPIRAMICIN B authKW 492511 2% 100% 1

Web of Science journal categories



Rank Term Chi square Shr. of publ. in
class containing
term
Class's shr. of
term's tot. occurrences
#P with
term in
class
1 Pharmacology & Pharmacy 263 39% 0% 24
2 Microbiology 168 23% 0% 14
3 Biotechnology & Applied Microbiology 139 21% 0% 13
4 Immunology 105 21% 0% 13
5 Oncology 88 21% 0% 13
6 Agronomy 74 10% 0% 6
7 Chemistry, Medicinal 58 10% 0% 6
8 Chemistry, Organic 40 13% 0% 8
9 Anesthesiology 14 3% 0% 2
10 Hematology 11 5% 0% 3

Address terms



Rank Term Chi square Shr. of publ. in
class containing
term
Class's shr. of
term's tot. occurrences
#P with
term in
class
1 FUNCT PAIN NEUROIMAGING THER Y 1313361 6% 67% 4
2 CENT 21142 NURUMIZU 886518 5% 60% 3
3 INPATIENT 1 492511 2% 100% 1
4 O BIOL ENDOCRINOL 492511 2% 100% 1
5 O CHIM 492511 2% 100% 1
6 BIOCHEM SETAGAYA KU 443256 5% 30% 3
7 PAIN MED PALLIAT CARE PROGRAM 246255 2% 50% 1
8 PLANT MORPHOL ANAT 246255 2% 50% 1
9 FO T PROD DEV UTILIZAT 70357 2% 14% 1
10 DUKE CANC CARE PROGRAM 28969 2% 6% 1

Journals



Rank Term Chi square Shr. of publ. in
class containing
term
Class's shr. of
term's tot. occurrences
#P with
term in
class
1 JOURNAL OF ANTIBIOTICS 12540 21% 0% 13
2 AGRICULTURAL AND BIOLOGICAL CHEMISTRY 1763 8% 0% 5
3 ANTIBIOTIKI I KHIMIOTERAPIYA 838 2% 0% 1
4 CAHIERS AGRICULTURES 766 2% 0% 1
5 CANCER CHEMOTHERAPY AND PHARMACOLOGY 601 5% 0% 3
6 JAPANESE JOURNAL OF CANCER RESEARCH 554 3% 0% 2
7 AFRICAN JOURNAL OF PHARMACY AND PHARMACOLOGY 459 2% 0% 1
8 ONCOLOGY RESEARCH 409 2% 0% 1
9 JOURNAL OF MEDICINAL PLANTS RESEARCH 288 2% 0% 1
10 CHEMICAL & PHARMACEUTICAL BULLETIN 254 5% 0% 3

Author Key Words



Rank Term Chi square Shr. of publ. in
class containing
term
Class's shr. of
term's tot. occurrences
#P with
term in
class
LCSH search Wikipedia search
1 KRN5500 5065827 19% 86% 12 Search KRN5500 Search KRN5500
2 SPICAMYCIN 3016630 11% 88% 7 Search SPICAMYCIN Search SPICAMYCIN
3 SPICAMYCIN DERIVATIVE 1477534 5% 100% 3 Search SPICAMYCIN+DERIVATIVE Search SPICAMYCIN+DERIVATIVE
4 3 D MODEL ANALYSIS 492511 2% 100% 1 Search 3+D+MODEL+ANALYSIS Search 3+D+MODEL+ANALYSIS
5 4 AMINO 4 DEOXYHEPTOSE 492511 2% 100% 1 Search 4+AMINO+4+DEOXYHEPTOSE Search 4+AMINO+4+DEOXYHEPTOSE
6 ANTIPLATELET AGGREGATORY 492511 2% 100% 1 Search ANTIPLATELET+AGGREGATORY Search ANTIPLATELET+AGGREGATORY
7 CANDIDATE ANTITUMOR DRUGS 492511 2% 100% 1 Search CANDIDATE+ANTITUMOR+DRUGS Search CANDIDATE+ANTITUMOR+DRUGS
8 DAPIRAMICIN B 492511 2% 100% 1 Search DAPIRAMICIN+B Search DAPIRAMICIN+B
9 GLUCAN FORMATION 492511 2% 100% 1 Search GLUCAN+FORMATION Search GLUCAN+FORMATION
10 LATOSILLAN 492511 2% 100% 1 Search LATOSILLAN Search LATOSILLAN

Core articles

The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.



Rank Reference # ref.
in cl.
Shr. of ref. in
cl.
Citations
1 MONS, S , FLEET, GWJ , (2003) AN APPROACH TO THE GENERATION OF SIMPLE ANALOGUES OF THE ANTITUMOUR AGENT SPICAMYCIN.ORGANIC & BIOMOLECULAR CHEMISTRY. VOL. 1. ISSUE 21. P. 3685 -3691 15 75% 4
2 SUZUKI, T , CHIDA, N , (2003) THE NEW AND EFFICIENT SYNTHESIS OF A HEPTOSE MOIETY OF SPICAMYCIN.CHEMISTRY LETTERS. VOL. 32. ISSUE 2. P. 190 -191 12 92% 5
3 GADGEEL, SM , BOINPALLY, RR , HEILBRUN, LK , WOZNIAK, A , JAIN, V , REDMAN, B , ZALUPSKI, M , WIEGAND, R , PARCHMENT, R , LORUSSO, PM , (2003) A PHASE I CLINICAL TRIAL OF SPICAMYCIN DERIVATIVE KRN5500 (NSC 650426) USING A PHASE I ACCELERATED TITRATION "2B" DESIGN.INVESTIGATIONAL NEW DRUGS. VOL. 21. ISSUE 1. P. 63-74 11 73% 4
4 MARTIN, A , BUTTERS, TD , FLEET, GWJ , (1999) SYNTHESIS AND BIOLOGICAL EVALUATION OF ENANTIOMERIC RHAMNOSE ANALOGUES OF THE ANTITUMOUR AGENT SPICAMYCIN - IS THE MODE OF ACTION BY MODIFICATION OF N-LINKED GLYCOPROTEINS?.TETRAHEDRON-ASYMMETRY. VOL. 10. ISSUE 12. P. 2343 -2360 12 75% 9
5 MIKI, H , OZAKI, S , NAKAMURA, S , ODA, A , AMOU, H , IKEGAME, A , WATANABE, K , HIASA, M , CUI, Q , HARADA, T , ET AL (2011) KRN5500, A SPICAMYCIN DERIVATIVE, EXERTS ANTI-MYELOMA EFFECTS THROUGH IMPAIRING BOTH MYELOMA CELLS AND OSTEOCLASTS.BRITISH JOURNAL OF HAEMATOLOGY. VOL. 155. ISSUE 3. P. 328-339 16 40% 1
6 MARTIN, A , BUTTERS, TD , FLEET, GWJ , (1998) A HIGHLY CYTOTOXIC L-RHAMNOSE ANALOGUE OF THE ANTITUMOUR AGENT SPICAMYCIN.CHEMICAL COMMUNICATIONS. VOL. . ISSUE 19. P. 2119 -2120 9 90% 3
7 SUPKO, JG , EDER, JP , RYAN, DP , SEIDEN, MV , LYNCH, TJ , AMREIN, PC , KUFE, DW , CLARK, JW , (2003) PHASE I CLINICAL TRIAL AND PHARMACOKINETIC STUDY OF THE SPICAMYCIN ANALOG KRN5500 ADMINISTERED AS A 1-HOUR INTRAVENOUS INFUSION FOR FIVE CONSECUTIVE DAYS TO PATIENTS WITH REFRACTORY SOLID TUMORS.CLINICAL CANCER RESEARCH. VOL. 9. ISSUE 14. P. 5178-5186 11 61% 8
8 SUZUKI, T , TANAKA, S , YAMADA, I , KOASHI, Y , YAMADA, K , CHIDA, N , (2000) TOTAL SYNTHESIS OF SPICAMYCIN AMINO NUCLEOSIDE.ORGANIC LETTERS. VOL. 2. ISSUE 8. P. 1137-1140 10 63% 27
9 CHIDA, N , (2008) TOTAL SYNTHESIS OF NUCLEOSIDE ANTIBIOTICS POSSESSING NOVEL N-GLYCOSIDE STRUCTURES.JOURNAL OF SYNTHETIC ORGANIC CHEMISTRY JAPAN. VOL. 66. ISSUE 11. P. 1105 -1115 16 25% 2
10 BYRD, JC , LUCAS, DM , MONE, AP , KITNER, JB , DRABICK, JJ , GREVER, MR , (2003) KRN5500: A NOVEL THERAPEUTIC AGENT WITH IN VITRO ACTIVITY AGAINST HUMAN B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA CELLS MEDIATES CYTOTOXICITY VIA THE INTRINSIC PATHWAY OF APOPTOSIS.BLOOD. VOL. 101. ISSUE 11. P. 4547-4550 8 47% 9

Classes with closest relation at Level 1



Rank Class id link
1 34669 ELSAMICIN A//CHARTREUSIN//N 1 NAPHTHYL SUCCINIMIDE
2 37002 EMPTY PODS//ACACIA NILOTICA//ACACIA NILOTICA L
3 15173 PATIENT DERIVED XENOGRAFT//FP3//PDX
4 36674 MACROPOROUS POLYMER CARRIER//IMMOBILIZED PAPAIN//SLIMICIDAL ACTIVITY
5 13855 5 NUCLEOTIDASE//CN II//PYRIMIDINE 5 NUCLEOTIDASE
6 34330 1 3 DINUCLEOPHILIC ADDITION//2 PROPENYL ISOCYANATE//BIOMED ESTRUTURAL MOL IBB CBME
7 3512 WOLFSON MED CHEM//INOSITOL PYROPHOSPHATE//INOSITIDE SIGNALING GRP
8 20537 PRODIGIOSIN//UNDECYLPRODIGIOSIN//CANC CELL BIOL GRP
9 27219 BACTERIOLOGICAL CODE//APPROVED LISTS OF BACTERIAL NAMES//SACCHAROMONOSPORA
10 28842 L HISTIDINOL//ZILASCORBH 2//SPARSOMYCIN

Go to start page